PXAI UK Audio Feed
05/08 20:55 theguardian.com

Soriot should explain the curious case of AstraZeneca’s non-deal

ASTRAZENECAPOLITICSBUSINESSPHARMACEUTICALS INDUSTRYMERGERS AND ACQUISITIONS
03/08 20:40 theguardian.com

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

BUSINESSPOLITICSECONOMYPHARMACEUTICALS INDUSTRYASTRAZENECA
03/08 10:10 theguardian.com

AstraZeneca holds talks with Bristol Myers Squibb over $400bn merger

POLITICSUS NEWSUK NEWSASTRAZENECABUSINESSPHARMACEUTICALS INDUSTRY
30/07 17:25 theguardian.com

‘So ... can I get this peptide?’: the loophole making way for the US’s ‘wild west’ of untested drugs

PHARMACEUTICALS INDUSTRYROBERT F KENNEDY JRSOCIETYPOLITICSHEALTHBUSINESS
28/07 20:50 theguardian.com

GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley

BUSINESSGSKPOLITICSUK NEWSPHARMACEUTICALS INDUSTRY
28/07 16:30 theguardian.com

GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

UK NEWSHERTFORDSHIREGSKPHARMACEUTICALS INDUSTRYPOLITICSSCIENCE
28/07 08:10 theguardian.com

Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit

JUSTICEHEALTHBUSINESSJOHNSON & JOHNSONPHARMACEUTICALS INDUSTRYUS NEWS
24/07 09:45 theguardian.com

Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

PHARMACEUTICALS INDUSTRYPOLITICSHEALTHAUSTRALIA NEWS
21/07 20:45 theguardian.com

Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

WEIGHT-LOSS DRUGSLAW (US)WORLD NEWSPHARMACEUTICALS INDUSTRYUS HEALTHCAREHEALTH
21/07 20:45 theguardian.com

Ozempic maker Novo Nordisk sues US rival over ‘materially misleading’ ads

WEIGHT-LOSS DRUGSLAW (US)WORLD NEWSPHARMACEUTICALS INDUSTRYUS HEALTHCAREHEALTH
UK Cluster Comments
Loading UK comments...
0